Minimally increased risk of cerebrovascular occlusive disease or intracerebral hemorrhage in patients on bevacizumab treatment and association with intracerebral malignancies
Oh Y, Wallace S, Taylor S, Herbst R, Lippman S, Karp D, Stewart D. Minimally increased risk of cerebrovascular occlusive disease or intracerebral hemorrhage in patients on bevacizumab treatment and association with intracerebral malignancies. Journal Of Clinical Oncology 2008, 26: 14507-14507. DOI: 10.1200/jco.2008.26.15_suppl.14507.Peer-Reviewed Original Research